EDSA

Edesa Biotech, Inc.

Edesa Biotech, Inc. (EDSA) has 18 SEC Form 4 filings (18 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 2, 2026.

The most active filer is Chief Executive Officer Nijhawan Pardeep with 3 filings.

  • Industry:Biotechnology
  • CEO:Pardeep Nijhawan
  • Employees:16
  • HQ:Markham, ON, CA
  • IPO:2010-06-21

Insider Buying

$89K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Market Cap

$47.7M

latest known value

Source
Brooks Michael JFirst filing
Purchase$3KMar 11SEC ↗
Purchase$7KMar 10SEC ↗
Purchase$43KMar 5SEC ↗
Nijhawan PardeepFirst filing
Purchase$36KMar 4SEC ↗

Related companies

Edesa Biotech, Inc. is in the Healthcare sector.